Irisin, a fascinating field in our times

Trends Endocrinol Metab. 2022 Sep;33(9):601-613. doi: 10.1016/j.tem.2022.06.003. Epub 2022 Jul 21.

Abstract

Irisin is a muscle-secreted hormone that is generated by cleavage of membrane protein FNDC-5 (fibronectin type III domain-containing protein 5). Irisin is considered to be a mediator of exercise-induced metabolic improvements, such as browning of white adipose tissue, and is known to alleviate several chronic non-metabolic diseases. Thus, irisin may be an ideal therapeutic target for metabolic and non-metabolic diseases. However, several controversies regarding irisin have hindered its clinical translation. We review the generation, regulation (especially in exercise), and metabolic as well as therapeutic effects of irisin on metabolic and non-metabolic diseases. Furthermore, we discuss controversies regarding irisin and highlight potential future research directions.

Keywords: FNDC-5; chronic disease; irisin; metabolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue, White / metabolism
  • Exercise / physiology
  • Fibronectins* / metabolism
  • Humans
  • Metabolic Diseases* / metabolism
  • Muscle, Skeletal / metabolism
  • Obesity / metabolism

Substances

  • Fibronectins